Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05069428
PHASE4

Delirium Reduction With Ramelteon

Sponsor: Centennial Medical Center

View on ClinicalTrials.gov

Summary

The overall purpose of this study is to identify a medication that might treat and/or prevent delirium in intensive care unit (ICU). Currently, there is no proven medical therapy for prevention or treatment of delirium. Ramelteon is a medication approved for insomnia. We hypothesize that ramelteon may help regulate the day/night cycle and decrease ICU delirium.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

506

Start Date

2023-03-26

Completion Date

2025-12

Last Updated

2024-08-22

Healthy Volunteers

No

Conditions

Interventions

DRUG

Ramelteon 8mg

administered crushed, orally at 20:30

Locations (1)

Centennial Medical Center

Nashville, Tennessee, United States